Cargando…
Combination treatment with artemisinin and oxaliplatin inhibits tumorigenesis in esophageal cancer EC109 cell through Wnt/β‐catenin signaling pathway
BACKGROUND: Esophageal cancer (EC) is a prevalent malignant cancer worldwide. Interestingly, the antimalaria compound artemisinin (ART) is also reported to have anticancer potential, although its underlying mechanism in EC is unclear. In this study, we explored the anticancer role of ART in EC109 an...
Autores principales: | Wang, Tao, Wang, Jian, Ren, Wei, Liu, Zhu‐Long, Cheng, Yu‐Feng, Zhang, Xiao‐Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396387/ https://www.ncbi.nlm.nih.gov/pubmed/32657048 http://dx.doi.org/10.1111/1759-7714.13570 |
Ejemplares similares
-
Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling
por: Tong, Yunli, et al.
Publicado: (2016) -
TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
por: Zhu, Linan, et al.
Publicado: (2018) -
Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells
por: Wang, Cong, et al.
Publicado: (2017) -
Effect of Food Additive Citric Acid on The Growth of
Human Esophageal Carcinoma Cell Line EC109
por: Chen, Xiaoguang, et al.
Publicado: (2017) -
ZNRF3 Inhibits the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Cells by Inactivating the Wnt/β-Catenin Pathway
por: Wang, Zhongwei, et al.
Publicado: (2017)